The FDA cleared Apollo Endosurgery's SuMO endoscopic tissue access and resection system, which allows surgeons to remove large, flat precancerous gastrointestinal lesions and polyps during endoscopy procedures without leaving scars, according to a news release.
FDA clears Apollo Endosurgery's SuMO endoscopic tissue access and resection system